We are live on ! Find out more
AA

ABC Arbitrage Portfolio holdings

AUM $926M
1-Year Est. Return 45.9%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+45.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
+$140M
Cap. Flow
+$89.6M
Cap. Flow %
8.82%
Top 10 Hldgs %
35.25%
Holding
314
New
116
Increased
37
Reduced
41
Closed
114

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$34.9M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$25.4M
3
HLN icon
Haleon
HLN
+$16.1M
4
ING icon
ING
ING
+$16M
5
FXI icon
iShares China Large-Cap ETF
FXI
+$15.7M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$25.3M
2
CX icon
Cemex
CX
+$15.5M
3
ERIC icon
Ericsson
ERIC
+$15M
4
MT icon
ArcelorMittal
MT
+$14.7M
5
SAP icon
SAP
SAP
+$11M

Sector Composition

Rank Sector Weight
1 Financials 17.47%
2 Healthcare 14.4%
3 Materials 11.62%
4 Consumer Staples 10.01%
5 Energy 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
Z icon
176
Zillow
Z
$7.7B
$332K 0.03%
+4,307
New +$352K
STZ icon
177
Constellation Brands
STZ
$22.5B
$316K 0.03%
+2,344
New +$373K
TRI icon
178
Thomson Reuters
TRI
$45.1B
$315K 0.03%
+1,995
New +$372K
PANW icon
179
Palo Alto Networks
PANW
$260B
$294K 0.03%
+1,445
New +$277K
IMOS
180
ChipMOS TECHNOLOGIES
IMOS
$1.73B
$290K 0.03%
+15,185
New +$268K
YUMC icon
181
Yum China
YUMC
$15.6B
$281K 0.03%
+6,557
New +$298K
ROP icon
182
Roper Technologies
ROP
$38.7B
$265K 0.03%
532
-2,831
-84% -$1.51M
BSX icon
183
Boston Scientific
BSX
$68.5B
$265K 0.03%
+2,717
New +$281K
EPP icon
184
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
$252K 0.02%
4,885
-10,656
-69% -$541K
SFM icon
185
Sprouts Farmers Market
SFM
$7.31B
$240K 0.02%
+2,210
New +$322K
CNP icon
186
CenterPoint Energy
CNP
$28.8B
$238K 0.02%
+6,124
New +$231K
IMVT icon
187
Immunovant
IMVT
$7.99B
$236K 0.02%
+14,639
New +$237K
SPCE icon
188
Virgin Galactic
SPCE
$320M
$228K 0.02%
59,171
-14,802
-20% -$49.6K
CHT icon
189
Chunghwa Telecom
CHT
$33.5B
$228K 0.02%
+5,230
New +$232K
IEV icon
190
iShares Europe ETF
IEV
$1.64B
$226K 0.02%
3,446
-10,484
-75% -$670K
NVR icon
191
NVR
NVR
$17.3B
$225K 0.02%
28
-2
-7% -$15.9K
LVS icon
192
Las Vegas Sands
LVS
$32B
$220K 0.02%
+4,084
New +$215K
ITW icon
193
Illinois Tool Works
ITW
$84.9B
$206K 0.02%
789
-3,657
-82% -$953K
AMGN icon
194
Amgen
AMGN
$212B
$206K 0.02%
729
-5,027
-87% -$1.46M
MCHI icon
195
iShares MSCI China ETF
MCHI
$6.16B
$205K 0.02%
+3,113
New +$187K
AAPG
196
Ascentage Pharma
AAPG
$1.71B
$204K 0.02%
+5,230
New +$212K
AHL
197
DELISTED
Aspen Insurance
AHL
$204K 0.02%
+5,545
New +$182K
UA icon
198
Under Armour Class C
UA
$2.97B
$56.4K 0.01%
+11,670
New +$65.3K
ABEV icon
199
Ambev
ABEV
$48.4B
$41.9K ﹤0.01%
+18,802
New +$43K
LGL.WS
200
DELISTED
LGL Group Inc Warrants
LGL.WS
$15.1K ﹤0.01%
+47,147
New +$19.4K

Similar funds

ABC Arbitrage's Q3 2025 Portfolio in Review

As of Q3 2025, ABC Arbitrage held 314 positions worth $1.02B, up 16% from $876M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

ABC Arbitrage deployed $89.6M of net new capital in Q3 2025, opening 116 new positions and adding to 37 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 407,107 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Ericsson, an estimated $15M trimmed.

  • ABC Arbitrage's largest Q3 2025 buy was iShares China Large-Cap ETF: 407,107 shares worth $16.7M.
  • ABC Arbitrage added most to AstraZeneca in Q3 2025, an estimated $34.9M increase.
  • ABC Arbitrage's biggest Q3 2025 reduction was Ericsson, cutting an estimated $15M.
  • ABC Arbitrage fully exited Novartis in Q3 2025, selling an estimated $25.3M.
  • ABC Arbitrage's ten largest holdings make up 35% of its $1.02B portfolio in Q3 2025.
  • ABC Arbitrage opened 116 new positions and closed 114 in Q3 2025.
  • ABC Arbitrage's portfolio value rose 16% quarter-over-quarter to $1.02B.

Based on ABC Arbitrage's 13F filing for Q3 2025, filed 6 Nov 2025.